Department of Defense (DoD).
Notice of meeting.
Pursuant to the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix as amended), the Sunshine in the Government Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, and in accordance with section 10(a)(2) of Public Law, the following meeting of the Defense Health Board (DHB) is announced.
March 9-10, 2009.
March 9, 2009
7 a.m.-12 p.m. (Open Session).
12 p.m.-2:15 p.m. (Administrative Working Meeting).
2:15 p.m.-5:15 p.m. (Open Session).
March 10, 2009
8 a.m.-4:30 p.m. (Administrative Working Meeting).
Flagler Ballroom, Marriott Beachside Hotel, 3841 North Roosevelt Boulevard, Key West, Florida 33040.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Commander Edmond F. Feeks, Executive Secretary, Defense Health Board, Five Skyline Place, 5111 Leesburg Pike, Suite 810, Falls Church, Virginia 22041-3206, (703) 681-8448, EXT. 1228, Fax: (703) 681-3317, firstname.lastname@example.org. Additional information, agenda updates, and meeting registration are available online at the Defense Health Board Web site, http://www.ha.osd.mil/dhb. The public is encouraged to register for the meeting. If special accommodations are required to attend (sign language, wheelchair accessibility) please contact Ms. Lisa Jarrett at (703) 681-8448 ext. 1280 by February 27, 2009. Written statements may be mailed to the above address, e-mailed to email@example.com or faxed to (703) 681-3317.End Further Info End Preamble Start Supplemental Information
Purpose of the Meeting: The purpose of the meeting is to address and deliberate pending and new Board issues and provide briefings for Board members on topics related to ongoing Board business.
Agenda: On March 9, 2009, the Board will receive briefings on military operations worldwide and in the Key West, Florida area. The following Defense Health Board Subcommittees will present updates to the Board: the Department of Defense Joint Pathology Center Work Group, the Task Force on the Review of the Department of Defense Biological Research Portfolio and Biodefense Infrastructure, the Psychological Health External Advisory Subcommittee, the Trauma and Injury Subcommittee, the Health Care Delivery External Advisory Subcommittee, the National Capital Region Base Realignment and Closure Subcommittee, and the Traumatic Brain Injury Family Caregivers Panel. The Board will also receive an informational briefing on the use of apheresis platelets and fresh whole blood in trauma situations. The Board will conduct administrative sessions in concert with the meeting on March 9, 2009 and on March 10, 2009. Pursuant to 41 Code of Federal Regulations, Part 102-3.160, the administrative working meetings are closed to the public.
Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102-3.140 through 102-3.165 and subject availability of space, the Defense Health Board meeting from 7 a.m. to 12 p.m. and from 2:15 p.m. to 5:15 p.m. on March 9, 2009 is open to the public. Any member of the public wishing to provide input to the Defense Health Board should submit a written statement in accordance with 41 CFR 102-3.140(C) and section 10(a)(3) of the Federal Advisory Committee Act, and the procedures described in this notice. Written statement should be not longer than two type-written pages and must address the following detail: The issue, discussion, and a recommended course of action. Supporting documentation may also be included as needed to establish the appropriate historical context and to provide any necessary background information.
Individuals desiring to submit a written statement may do so through the Board's Designated Federal Officer at the address detailed above at any point. However, if the written statement is not received at least 10 calendar days prior to the meeting, which is subject to this notice, then it may not be provided to or considered by the Defense Health Board until the next open meeting.
The Designated Federal Officer will review all timely submissions with the Defense Health Board Chairperson, and ensure they are provided to members of the Defense Health Board before the meeting that is subject to this notice. After reviewing the written comments, the Chairperson and the Designated Federal Officer may choose to invite the submitter of the comments to orally present their issue during an open portion of this meeting or at a future meeting.
The Designated Federal Officer, in consultation with the Defense Health Board Chairperson, may, if desired, allot a specific amount of time for members of the public to present their issues for review and discussion by the Defense Health Board.Start Signature
Dated: February 17, 2009.
Patricia L. Toppings,
OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. E9-3767 Filed 2-20-09; 8:45 am]
BILLING CODE 5001-06-P